Enara Bio Competitors and Similar CompaniesClear all
Enara Bio's competitors and similar companies include ImmunoGen, Scorpion Therapeutics, Aeglea and Odyssey Therapeutics.
 Enara Bio Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Odyssey Therapeutics Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines. | ||
Founding Date | Founding Date 2016 | Founding Date 1981 | Founding Date 2020 | Founding Date 2013 | Founding Date 2021 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Oxford, GB HQ London, GB London, GB Oxford, GB | Locations Waltham, US HQ | Locations Boston, US HQ Boston, US South San Francisco, US | Locations Austin, US HQ | Locations Boston, US HQ Frankfurt Am Main, DE Ann Arbor, US San Diego, US |
Employees | Employees 622% increase | Employees 277161% increase | Employees 1213% decrease | Employees 65117% increase | Employees 1481% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.7 b | Valuation ($) N/A | Valuation ($) 48.6 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($222.9m) (FY, 2022) | Net income N/A | Net income ($155.2m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 17.5m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 108m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 17.5m | Total funding raised $ 56m | Total funding raised $ 108m | Total funding raised N/A | Total funding raised $ 386m |
For sources of this data, please see the company profile
View Company Profiles
ImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company
Scorpion Therapeutics
HQ
Boston, US
Employees
121↓ 3% decrease
Scorpion Therapeutics is a company that develops cancer treatments.
View companyAeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyOdyssey Therapeutics
HQ
Boston, US
Employees
148↓ 1% decrease
Odyssey Therapeutics is a company that develops precision immunomodulators and oncology medicines.
View company